Ad
related to: commercialization plan
Search results
TotalEnergies commits $600M to Congo oil field development By Investing.com
Investing.com· 3 days agoTotalEnergies (EPA:TTEF), a major player in the oil and gas industry, has announced a significant...
STRADVISION Achieves 'A, A' Rating in KOSDAQ Technology Special Listing Evaluation, Accelerating IPO...
FOX 4 Kansas City· 6 days agoSTRADVISION, the creator of award winning AI-powered image recognition software 'SVNet', is proud to announce its successful completion of the technology evaluation for the KOSDAQ technology ...
Will schools finally pay student-athletes? What a historic settlement means for the NCAA and players
NBC News via Yahoo Sports· 2 days agoPaul Haagen, a law professor at Duke University, said the result could mean schools cutting programs...
Inhibrx Inc. Stockholders Approve Sale of INBRX-101 to Sanofi
KPVI· 2 days agoInhibrx, Inc. (Nasdaq: INBX) ("Inhibrx," or the "Company") announced that, at a special meeting (the "Special Meeting"), the Company's stockholders approved the sale to Sanofi of all the assets ...
Meatable appoints beef industry veteran as CEO
Food Dive via Yahoo Finance· 4 days agoBanks, currently the CEO of Flagship Pioneering, a leading biotechnology company said “Meatable has enormous potential to disrupt the cultivated meat...
Biogen to buy Peninsula startup developing a drug for kidney disease for $1.2 billion - San...
The Business Journals· 4 days agoThe Cambridge, Massachusetts-based drugmaker (Nasdaq: BIIB) said on Wednesday it's buying Human...
“From the consumer feedback we get, we will succeed” – Go Free founder on trying to disrupt...
Just Food via Yahoo Finance· 5 days agoFood-industry veteran Jamshid Ashourian is looking to shake up the world of snacks. Ashourian and...
Earnings call: ClearSign Technologies Q1 2024 financial performance By Investing.com
Investing.com· 2 days agoClearSign Technologies (ticker symbol not provided) has announced its financial results for the...
Biogen to buy San Francisco startup developing a drug for kidney disease for $1.2B - Boston Business...
The Business Journals· 4 days agoThe Cambridge drugmaker (Nasdaq: BIIB) said on Wednesday it's buying Human Immunology Biosciences,...
BioLineRx Announces Abstract on Pilot Study Data from Phase 2 Combination Clinical Trial Evaluating...
FOX 23 News Albany· 2 days agoBioLineRx Ltd. (NASDAQ: BLRX) (TASE: BLRX), a commercial stage biopharmaceutical company pursuing...
